Stop Exogenous Allergic Alveolitis (EAA) in Childhood
Status:
Suspended
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Stop exogenous allergic alveolitis (EAA) in childhood: healthy into adulthood - a randomized,
double-blind, placebo-controlled, parallel-group study to evaluate prednisolone treatment and
course of disease.
The hypothesis of the study is that the treatment with placebo will not be inferior in terms
of Forced Vital Capacity (FVC) improvement than treatment with systemic steroids after 6
months treatment.